Using 5-aminolevulinic acid and pulsed dye laser for photodynamic treatment of oral leukoplakia

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 11, 2011, Pages 1117-1123

  Shafirstein, Gal ^a,b   Friedman, Adva ^a,b   Siegel, Eric ^a   Moreno, Mauricio ^a,b   Bäumler, Wolfgang ^c   Fan, Chun Yang ^a,d   Morehead, Kimberly ^a,b   Vural, Emre ^a,b,d   Stack Jr , Brendan C ^a,b   Suen, James Y ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Jackson T Stephens Spine and Neurosciences Institute   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; MOUTH PAIN; MOUTH ULCER; PHOTODYNAMIC THERAPY; PULSED DYE LASER; SENSORY DYSFUNCTION; SIDE EFFECT; SWELLING; TASTE; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AMINOLEVULINIC ACID; BIOPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY; LASERS, DYE; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 81855211095     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.178     Document Type: Article

References (21)

1. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst Rev. 2006;(4):CD001829.
2. Vivek V, Jayasree RS, Balan A, Sreelatha KT, Gupta AK. Three-year follow-up of oral leukoplakia after neodymium:yttrium aluminum garnet (Nd:YAG) laser surgery. Lasers Med Sci. 2008;23(4):375-379.
3. 2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol. 2005;41(1):31-37.
4. Sankaranarayanan R, Mathew B, Varghese C, et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol. 1997;33(4):231-236.
5. Epstein JB, Gorsky M, Wong FL, Millner A. Topical bleomycin for the treatment of dysplastic oral leukoplakia. Cancer. 1998;83(4):629-634. (Pubitemid 28387683)
6. Tradati N, Chiesa F, Rossi N, et al. Successful topical treatment of oral lichen planus and leukoplakias with fenretinide (4-HPR). Cancer Lett. 1994;76(2-3):109-111. (Pubitemid 24068284)
7. Chen HM, Yu CH, Tu PC, Yeh CY, Tsai T, Chiang CP. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy. Lasers Surg Med. 2005;37(2):114-122. (Pubitemid 41266294)
8. Sieroń A, Adamek M, Kawczyk-Krupka A, Mazur S, Ilewicz L. Photodynamic therapy (PDT) using topically applied δ-aminolevulinic acid (ALA) for the treatment of oral leukoplakia. J Oral Pathol Med. 2003;32(6):330-336. (Pubitemid 36781531)
9. Langer S, Abels C, Botzlar A, et al. Active and higher intracellular uptake of 5-aminolevulinic acid in tumors may be inhibited by glycine. J Invest Dermatol. 1999; 112(5):723-728. (Pubitemid 29220714)
10. Szeimies RM, Sassy T, Landthaler M. Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol. 1994;59(1):73-76. (Pubitemid 2043025)
11. Marcus SL, McIntyre WR. Photodynamic therapy systems and applications. Expert Opin Emerg Drugs. 2002;7(2):321-334. (Pubitemid 35291461)
12. Karrer S, Bäumler W, Abels C, Hohenleutner U, Landthaler M, Szeimies RM. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med. 1999;25(1):51-59. (Pubitemid 29379091)
13. Alexiades-Armenakas M. Aminolevulinic acid photodynamic therapy for actinic keratoses/actinic cheilitis/acne: vascular lasers. Dermatol Clin. 2007;25(1):25-33. (Pubitemid 44780058)
14. Orringer JS, Sachs DL, Bailey E, Kang S, Hamilton T, Voorhees JJ. Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy. J Cosmet Dermatol. 2010;9(1):28-34.
15. Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol. 2005;153(4):780-784. (Pubitemid 41415905)
16. Franco RA Jr. Aminolevulinic acid 585 nm pulsed dye laser photodynamic treatment of laryngeal keratosis with atypia. Otolaryngol Head Neck Surg. 2007;136(6):882-887.
17. Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003;14(1):47-62.
18. Storer BE. Design and analysis of phase I clinical trials. Biometrics. 1989;45(3):925-937. (Pubitemid 19249331)
19. Strasswimmer J, Grande DJ. Do pulsed lasers produce an effective photodynamic therapy response? Lasers Surg Med. 2006;38(1):22-25. (Pubitemid 43238081)
20. Passeron T, Khemis A, Ortonne JP. Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: a pilot study on four cases. J Dermatolog Treat. 2009;20(5):297-298.
21. Bashkatov AN, Genina EA, Kochubey VI, Tuchin VV. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D Appl Phys. 2005;38(15):2543-2555. doi:10.1088/0022-3727/38/15/ 004. (Pubitemid 41067742)